Bruker Corporation (BRKR)
USD 36.32
(-3.56%)
USD 36.32
(-3.56%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.24 Billion USD | 17.45% |
| 2022 | 3.61 Billion USD | -0.86% |
| 2021 | 3.65 Billion USD | 19.75% |
| 2020 | 3.04 Billion USD | 9.97% |
| 2019 | 2.77 Billion USD | 30.2% |
| 2018 | 2.12 Billion USD | 9.24% |
| 2017 | 1.94 Billion USD | 7.48% |
| 2016 | 1.81 Billion USD | 4.74% |
| 2015 | 1.73 Billion USD | -7.18% |
| 2014 | 1.86 Billion USD | -6.21% |
| 2013 | 1.98 Billion USD | 7.11% |
| 2012 | 1.85 Billion USD | 8.53% |
| 2011 | 1.71 Billion USD | 10.37% |
| 2010 | 1.54 Billion USD | 32.24% |
| 2009 | 1.17 Billion USD | 4.99% |
| 2008 | 1.11 Billion USD | 101.78% |
| 2007 | 553.21 Million USD | 27.71% |
| 2006 | 433.18 Million USD | 20.03% |
| 2005 | 360.88 Million USD | -2.87% |
| 2004 | 371.54 Million USD | 5.84% |
| 2003 | 351.03 Million USD | 72.83% |
| 2002 | 203.1 Million USD | 7.42% |
| 2001 | 189.07 Million USD | 2.45% |
| 2000 | 184.55 Million USD | 174.19% |
| 1999 | 67.3 Million USD | 5.43% |
| 1998 | 63.84 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 6.11 Billion USD | 3.56% |
| 2024 Q1 | 4.5 Billion USD | 6.04% |
| 2024 Q2 | 5.9 Billion USD | 30.98% |
| 2023 Q2 | 3.85 Billion USD | 2.47% |
| 2023 FY | 4.24 Billion USD | 17.45% |
| 2023 Q1 | 3.76 Billion USD | 4.02% |
| 2023 Q3 | 3.81 Billion USD | -1.01% |
| 2023 Q4 | 4.24 Billion USD | 11.31% |
| 2022 Q4 | 3.61 Billion USD | 8.44% |
| 2022 FY | 3.61 Billion USD | -0.86% |
| 2022 Q1 | 3.56 Billion USD | -2.29% |
| 2022 Q2 | 3.38 Billion USD | -5.09% |
| 2022 Q3 | 3.33 Billion USD | -1.42% |
| 2021 Q4 | 3.65 Billion USD | 16.76% |
| 2021 FY | 3.65 Billion USD | 19.75% |
| 2021 Q2 | 3.08 Billion USD | 1.72% |
| 2021 Q3 | 3.12 Billion USD | 1.26% |
| 2021 Q1 | 3.03 Billion USD | -0.43% |
| 2020 Q2 | 2.94 Billion USD | -0.62% |
| 2020 Q1 | 2.96 Billion USD | 6.87% |
| 2020 Q3 | 2.87 Billion USD | -2.17% |
| 2020 Q4 | 3.04 Billion USD | 5.85% |
| 2020 FY | 3.04 Billion USD | 9.97% |
| 2019 Q1 | 2.24 Billion USD | 5.35% |
| 2019 Q4 | 2.77 Billion USD | 17.83% |
| 2019 Q3 | 2.35 Billion USD | 0.1% |
| 2019 FY | 2.77 Billion USD | 30.2% |
| 2019 Q2 | 2.34 Billion USD | 4.78% |
| 2018 FY | 2.12 Billion USD | 9.24% |
| 2018 Q2 | 1.8 Billion USD | -1.34% |
| 2018 Q3 | 1.88 Billion USD | 4.6% |
| 2018 Q4 | 2.12 Billion USD | 12.68% |
| 2018 Q1 | 1.83 Billion USD | -6.06% |
| 2017 Q3 | 1.96 Billion USD | 2.54% |
| 2017 FY | 1.94 Billion USD | 7.48% |
| 2017 Q4 | 1.94 Billion USD | -0.66% |
| 2017 Q1 | 1.83 Billion USD | 1.49% |
| 2017 Q2 | 1.91 Billion USD | 3.97% |
| 2016 FY | 1.81 Billion USD | 4.74% |
| 2016 Q2 | 1.72 Billion USD | -1.11% |
| 2016 Q3 | 1.79 Billion USD | 4.5% |
| 2016 Q1 | 1.73 Billion USD | 0.51% |
| 2016 Q4 | 1.81 Billion USD | 0.83% |
| 2015 Q2 | 1.82 Billion USD | 2.69% |
| 2015 Q4 | 1.73 Billion USD | -6.08% |
| 2015 Q3 | 1.84 Billion USD | 1.24% |
| 2015 FY | 1.73 Billion USD | -7.18% |
| 2015 Q1 | 1.77 Billion USD | -4.94% |
| 2014 Q2 | 2 Billion USD | -1.17% |
| 2014 Q4 | 1.86 Billion USD | -2.4% |
| 2014 Q3 | 1.91 Billion USD | -4.66% |
| 2014 Q1 | 2.02 Billion USD | 1.98% |
| 2014 FY | 1.86 Billion USD | -6.21% |
| 2013 Q2 | 1.8 Billion USD | -0.56% |
| 2013 Q3 | 1.93 Billion USD | 7.46% |
| 2013 FY | 1.98 Billion USD | 7.11% |
| 2013 Q1 | 1.81 Billion USD | -2.4% |
| 2013 Q4 | 1.98 Billion USD | 2.69% |
| 2012 Q3 | 1.8 Billion USD | 2.85% |
| 2012 FY | 1.85 Billion USD | 8.53% |
| 2012 Q2 | 1.75 Billion USD | -2.63% |
| 2012 Q4 | 1.85 Billion USD | 3.13% |
| 2012 Q1 | 1.79 Billion USD | 5.07% |
| 2011 FY | 1.71 Billion USD | 10.37% |
| 2011 Q3 | 1.67 Billion USD | -1.74% |
| 2011 Q2 | 1.69 Billion USD | 4.68% |
| 2011 Q1 | 1.62 Billion USD | 4.78% |
| 2011 Q4 | 1.71 Billion USD | 2.4% |
| 2010 Q1 | 1.15 Billion USD | -1.06% |
| 2010 FY | 1.54 Billion USD | 32.24% |
| 2010 Q4 | 1.54 Billion USD | 21.35% |
| 2010 Q3 | 1.27 Billion USD | 11.98% |
| 2010 Q2 | 1.14 Billion USD | -1.65% |
| 2009 Q1 | 1.05 Billion USD | -5.12% |
| 2009 Q4 | 1.17 Billion USD | 4.25% |
| 2009 Q3 | 1.12 Billion USD | 3.37% |
| 2009 FY | 1.17 Billion USD | 4.99% |
| 2009 Q2 | 1.08 Billion USD | 2.68% |
| 2008 Q1 | 1.39 Billion USD | 152.6% |
| 2008 Q3 | 1.07 Billion USD | -8.02% |
| 2008 Q4 | 1.11 Billion USD | 3.6% |
| 2008 Q2 | 1.17 Billion USD | -16.17% |
| 2008 FY | 1.11 Billion USD | 101.78% |
| 2007 Q3 | 498.36 Million USD | 8.23% |
| 2007 Q2 | 460.48 Million USD | -0.56% |
| 2007 FY | 553.21 Million USD | 27.71% |
| 2007 Q1 | 463.09 Million USD | 6.9% |
| 2007 Q4 | 553.21 Million USD | 11.01% |
| 2006 FY | 433.18 Million USD | 20.03% |
| 2006 Q4 | 433.18 Million USD | 5.82% |
| 2006 Q3 | 409.36 Million USD | 7.81% |
| 2006 Q2 | 379.72 Million USD | 2.63% |
| 2006 Q1 | 369.98 Million USD | 2.52% |
| 2005 Q1 | 367.44 Million USD | -1.1% |
| 2005 Q2 | 350.04 Million USD | -4.74% |
| 2005 FY | 360.88 Million USD | -2.87% |
| 2005 Q4 | 360.88 Million USD | 2.72% |
| 2005 Q3 | 351.34 Million USD | 0.37% |
| 2004 FY | 371.54 Million USD | 5.84% |
| 2004 Q1 | 345.31 Million USD | -1.63% |
| 2004 Q2 | 348.14 Million USD | 0.82% |
| 2004 Q3 | 353.98 Million USD | 1.68% |
| 2004 Q4 | 371.54 Million USD | 4.96% |
| 2003 Q1 | 211.53 Million USD | 4.15% |
| 2003 Q4 | 351.03 Million USD | 3.52% |
| 2003 Q3 | 339.08 Million USD | 57.33% |
| 2003 Q2 | 215.52 Million USD | 1.89% |
| 2003 FY | 351.03 Million USD | 72.83% |
| 2002 Q2 | 201.14 Million USD | 3.79% |
| 2002 Q1 | 193.8 Million USD | 2.5% |
| 2002 FY | 203.1 Million USD | 7.42% |
| 2002 Q4 | 203.1 Million USD | 2.63% |
| 2002 Q3 | 197.9 Million USD | -1.61% |
| 2001 Q3 | 187.82 Million USD | 1.57% |
| 2001 FY | 189.07 Million USD | 2.45% |
| 2001 Q4 | 189.07 Million USD | 0.67% |
| 2001 Q2 | 184.92 Million USD | -0.42% |
| 2001 Q1 | 185.7 Million USD | 0.63% |
| 2000 Q4 | 184.55 Million USD | 6.7% |
| 2000 Q1 | 71.23 Million USD | 0.0% |
| 2000 FY | 184.55 Million USD | 174.19% |
| 2000 Q2 | 71.37 Million USD | 0.19% |
| 2000 Q3 | 172.95 Million USD | 142.33% |
| 1999 FY | 67.3 Million USD | 5.43% |
| 1998 FY | 63.84 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -13449.385% |
| BrainsWay Ltd. | 62.97 Million USD | -6648.873% |
| Cerus Corporation | 197.74 Million USD | -2049.149% |
| Envoy Medical, Inc. | 7.64 Million USD | -55526.963% |
| electroCore, Inc. | 16.38 Million USD | -25834.582% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -55150.91% |
| IceCure Medical Ltd | 16.41 Million USD | -25798.233% |
| Inogen, Inc. | 326.19 Million USD | -1202.875% |
| OrthoPediatrics Corp. | 449.58 Million USD | -845.292% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -15484.525% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -25534.222% |
| MaxCyte, Inc. | 268.27 Million USD | -1484.164% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -52385.306% |
| Nexalin Technology, Inc. | 3.63 Million USD | -116915.371% |
| Orthofix Medical Inc. | 925.31 Million USD | -359.292% |
| PAVmed Inc | 33.11 Million USD | -12732.211% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -2862.594% |
| RxSight, Inc. | 182.55 Million USD | -2228.074% |
| Sight Sciences, Inc. | 166.65 Million USD | -2450.18% |
| SI-BONE, Inc. | 230.42 Million USD | -1744.375% |
| TELA Bio, Inc. | 78.04 Million USD | -5345.239% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | -1587.091% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -39507.642% |
| Acutus Medical, Inc. | 53.96 Million USD | -7776.019% |
| Talis Biomedical Corporation | 98.34 Million USD | -4221.639% |
| Spectral AI, Inc. | 10.69 Million USD | -39648.41% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -1843.718% |
| CVRx, Inc. | 115.22 Million USD | -3588.221% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -7144.848% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -136322.307% |
| Bioventus Inc. | 810.91 Million USD | -424.09% |
| Venus Concept Inc. | 93.65 Million USD | -4437.873% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -16420.505% |
| LivaNova PLC | 2.42 Billion USD | -74.924% |
| 908 Devices Inc. | 202.98 Million USD | -1993.743% |
| Alphatec Holdings, Inc. | 805.2 Million USD | -427.802% |
| Nemaura Medical Inc. | 14.56 Million USD | -29082.394% |
| NeuroPace, Inc. | 107.65 Million USD | -3847.85% |
| LENSAR, Inc. | 69.58 Million USD | -6007.494% |
| Apyx Medical Corporation | 79.24 Million USD | -5263.327% |
| Cutera, Inc. | 346.29 Million USD | -1127.263% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -10014.956% |
| BioSig Technologies, Inc. | 1.79 Million USD | -236268.187% |
| Anika Therapeutics, Inc. | 270.63 Million USD | -1470.361% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -9862.026% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | -12.372% |
| Axonics, Inc. | 719.92 Million USD | -490.327% |
| Outset Medical, Inc. | 313.8 Million USD | -1254.33% |
| IRIDEX Corporation | 34.43 Million USD | -12241.445% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | -950.092% |
| IRadimed Corporation | 92.15 Million USD | -4511.632% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -80788.847% |
| INVO Bioscience, Inc. | 20.88 Million USD | -20246.339% |
| Telesis Bio, Inc. | 70.41 Million USD | -5935.847% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -2657.84% |
| Varex Imaging Corporation | 1.24 Billion USD | -240.101% |
| Quipt Home Medical Corp. | 247.4 Million USD | -1617.77% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -45548.765% |
| Pulmonx Corporation | 178.95 Million USD | -2274.896% |
| Dynatronics Corporation | 25.94 Million USD | -16283.224% |
| Modular Medical, Inc. | 13.8 Million USD | -30680.763% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -39518.719% |
| Semler Scientific, Inc. | 78.06 Million USD | -5344.053% |
| InMode Ltd. | 863.28 Million USD | -392.293% |
| Cytosorbents Corporation | 53.26 Million USD | -7879.439% |
| DexCom, Inc. | 6.26 Billion USD | 32.159% |
| Align Technology, Inc. | 6.08 Billion USD | 30.145% |
| Viveve Medical, Inc. | 25.91 Million USD | -16300.648% |
| ZimVie Inc. | 1.2 Billion USD | -252.588% |
| Movano Inc. | 9.42 Million USD | -45010.922% |
| Cytek Biosciences, Inc. | 497.66 Million USD | -753.961% |
| Nexalin Technology, Inc. | 3.63 Million USD | -116915.371% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -7144.848% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | -346.11% |
| Profound Medical Corp. | 43.68 Million USD | -9628.213% |
| Insulet Corporation | 2.58 Billion USD | -64.203% |
| enVVeno Medical Corporation | 48.63 Million USD | -8638.357% |
| Surmodics, Inc. | 185.73 Million USD | -2188.177% |
| iCAD, Inc. | 41.41 Million USD | -10160.998% |
| Nuwellis, Inc. | 9.77 Million USD | -43399.488% |
| Biotricity, Inc. | 5.94 Million USD | -71415.534% |
| iRhythm Technologies, Inc. | 433.14 Million USD | -881.175% |
| Aethlon Medical, Inc. | 8.24 Million USD | -51439.04% |
| InspireMD, Inc. | 47.64 Million USD | -8820.303% |
| PAVmed Inc. | 33.11 Million USD | -12732.211% |
| BIOLASE, Inc. | 35.1 Million USD | -12007.632% |
| Beyond Air, Inc. | 56.96 Million USD | -7361.07% |
| FONAR Corporation | 214.24 Million USD | -1883.655% |
| AxoGen, Inc. | 196.82 Million USD | -2059.206% |
| Vivani Medical, Inc. | 45.79 Million USD | -9179.865% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | -1410.066% |
| Inari Medical, Inc. | 674.23 Million USD | -530.329% |
| UFP Technologies, Inc. | 404.13 Million USD | -951.601% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -18063.082% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -44621.135% |
| Tenon Medical, Inc. | 6.34 Million USD | -66880.299% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -45078.059% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -4000.331% |
| AdaptHealth Corp. | 4.61 Billion USD | 8.007% |
| Sintx Technologies, Inc. | 15.36 Million USD | -27559.616% |
| NanoVibronix, Inc. | 6.67 Million USD | -63578.454% |
| Quanterix Corporation | 425.01 Million USD | -899.951% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -45548.765% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -7810.176% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | -143.406% |
| TransMedics Group, Inc. | 706.04 Million USD | -501.929% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -6625.377% |
| NeuroMetrix, Inc. | 21.42 Million USD | -19736.69% |
| Hyperfine, Inc. | 94.19 Million USD | -4411.619% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | -1482.0% |
| Biomerica, Inc. | 9.25 Million USD | -45825.005% |
| Bone Biologics Corporation | 3.73 Million USD | -113601.698% |
| AVITA Medical, Inc. | 144.33 Million USD | -2844.368% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -87193.272% |
| Silk Road Medical, Inc | 265.3 Million USD | -1501.868% |